前循环大血管闭塞性急性缺血性卒中行血管内治疗血管成功再通后术中DSA静脉早显及毛细血管充血与术后出血转化及其亚型的关系OA
目的 探索前循环大血管闭塞性急性缺血性卒中(LVO-AIS)行血管内治疗(EVT)血管成功再通后术中DSA静脉早显(EVD)和毛细血管充血(CB)与出血转化(HT)及其严重亚型——脑实质出血2 型(PH2)和症状性颅内出血(sICH)的关系.方法 回顾性连续纳入2022 年10 月至2024 年7 月河南省人民医院脑血管病科收治的发病24h内行EVT且血管成功再通[术后即刻改良脑梗死溶栓(mTICI)分级≥2b级]的前循环LVO-AIS患者.收集患者的一般及临床资料,包括性别、年龄、高血压病、糖尿病、高脂血症、冠心病、心房颤动、吸烟史、饮酒史、既往卒中、入院美国国立卫生研究院卒中量表(NIHSS)评分、入院格拉斯哥昏迷量表(GCS)评分、入院Alberta卒中项目早期CT评分(ASPECTS)、急性卒中治疗Org 10172 试验(TOAST)分型(动脉粥样硬化型、心源性栓塞型、其他病因型、不明原因型)、治疗时间窗[发病至穿刺时间(OPT)≤6 h,>6~<12 h,12~24 h]、闭塞部位(颈内动脉、大脑中动脉M1 段或M2 段、大脑前动脉A1 段、串联闭塞)、术前静脉溶栓、血管开通技术(机械取栓、直接血管成形、机械取栓+补救血管成形)、OPT、穿刺至血管成功再通时间、发病至血管成功再通时间及入院血液检查指标[中性粒细胞、淋巴细胞计数、血小板计数、纤维蛋白原、血糖、中性粒细胞与淋巴细胞比值(NLR)、全身免疫炎症指数(SII)].血管成功再通后DSA中存在EVD为EVD+,不存在EVD为EVD-,存在CB为CB+,不存在CB为CB-,存在EVD但不存在CB为EVD+CB-,不存在EVD但存在CB为EVD-CB+,存在EVD和CB为EVD+CB+,存在EVD和(或)CB为EVD+/CB+.术后72h行CT评估是否发生HT、PH2 和sICH.不存在颅内出血的患者为无HT组;存在任何类型颅内出血的患者为HT组;血肿体积>梗死体积的30%,并存在明显占位效应的出血或远离梗死灶出血的患者为PH2 组;sICH为存在任何形式的颅内出血且伴随神经功能恶化(NIHSS评分较基线增加≥4 分或NIHSS中任意一项评分较基线增加≥2 分)的患者为sICH组.将无HT组与其他3 组比较差异有统计学意义的因素采用逐步向前回归筛选变量并进行多因素Logistic回归分析,分析前循环LVO-AIS患者EVT术后72h发生HT、PH2 和sICH的影响因素.绘制受试者工作特征(ROC)曲线并计算曲线下面积(AUC),评估EVD+CB+与EVD+/CB+对HT、PH2 及sICH的预测效能.结果 共纳入190 例行EVT后血管成功再通的前循环LVO-AIS患者,男112 例,女78 例,年龄25~84 岁,平均(63±14)岁.术后HT组患者39 例(20.5%),PH2 组患者18 例(9.5%),sICH组患者18 例(9.5%),其中13 例(6.8%)患者为PH2 和sICH.术后即刻DSA显示EVD+患者20 例(10.5%),CB+患者45 例(23.7%),EVD+CB-患者5 例(2.6%),EVD-CB+患者30 例(15.8%),EVD+CB+患者15 例(7.9%).(1)与无HT组患者相比,HT组患者入院NIHSS评分、血糖、NLR及SII均更高,入院GCS评分、入院ASPECTS、淋巴细胞计数和血小板计数均更低,EVD-CB+、EVD+CB+及EVD+/CB+患者比例均更高(均P<0.05),余一般及临床资料的组间差异均无统计学意义(均P>0.05);与无HT组患者相比,PH2 组患者入院ASPECTS更低,糖尿病患者比例、血糖NLR及SII均更高,EVD+CB+和EVD+/CB+患者比例均更高(均P<0.05),余一般及临床资料的组间差异均无统计学意义(均P>0.05);与无HT组相比,sICH组患者入院ASPECTS、淋巴细胞计数和血小板计数均更低,NLR、SII均更高,EVD+CB+和EVD+/CB+患者比例均更高(均P<0.01),余一般及临床资料的组间差异均无统计学意义(均P>0.05).(2)多因素Logistic回归分析结果显示,高血小板计数(OR=0.992,95%CI:0.985~0.999,P=0.022)和高入院ASPECTS(OR=0.607,95%CI:0.424~0.871,P=0.007)为前循环LVO-AIS患者行EVT血管成功再通后发生HT的独立保护因素,EVD+CB+(OR=8.664,95%CI:1.533~48.953,P=0.015)及EVD+/CB+(OR=5.866,95%CI:2.261~15.217,P<0.01)均为前循环LVO-AIS患者行EVT血管成功再通后发生HT的独立危险因素;高入院ASPECTS(OR=0.595,95%CI:0.362~0.975,P=0.039)为前循环LVO-AIS患者行EVT血管成功再通后发生PH2 的独立保护因素,EVD+CB+(OR=25.450,95%CI:3.719~174.158,P<0.01)和EVD+/CB+(OR=7.747,95%CI:1.664~36.066,P=0.009)为前循环LVO-AIS患者行EVT血管成功再通后发生PH2 的独立危险因素;高入院ASPECTS为前循环LVO-AIS患者行EVT血管成功再通后发生sICH的独立保护因素(OR=0.563,95%CI:0.357~0.888,P=0.014),EVD+CB+为前循环LVO-AIS患者行EVT血管成功再通后发生sICH的独立危险因素(OR=52.576,95%CI:7.866~351.432,P<0.01).(3)ROC曲线分析显示,EVD+CB+预测前循环LVO-AIS患者行EVT血管成功再通后发生HT、PH2 及sICH的AUC分别为0.660、0.771 和0.716;EVD+/CB+预测前循环LVO-AIS患者行EVT血管成功再通后发生HT、PH2 及sICH的AUC分别为0.754、0.837 和0.726.结论 EVT术中联合评估EVD和CB对前循环LVO-AIS患者血管成功再通后发生HT、PH2 和sICH具有一定的预测效能,或可作为术中识别高出血风险患者的实时影像学标志物.
Objective To investigate the association between intraprocedural DSA signs-specifically early venous drainage(EVD)and capillary blush(CB)-observed following successful endovascular treatment(EVT)recanalization,with hemorrhagic transformation(HT)and its severe subtypes,parenchymal hematoma type 2(PH2)and symptomatic intracranial hemorrhage(sICH),in patients with anterior circulation large vessel occlusion acute ischemic stroke(LVO-AIS).Methods This study retrospectively and consecutively enrolled patients with anterior circulation LVO-AIS who underwent EVT within 24 hours of symptom onset and achieved successful recanalization(defined as a post-procedural modified thrombolysis in cerebral infarction[mTICI]grade≥2b)at the Department of Cerebrovascular Diseases,Henan Provincial People's Hospital between October 2022 and July 2024.Patient demographics and clinical data were collected,including gender,age,history of hypertension,diabetes,hyperlipidemia,coronary heart disease,atrial fibrillation,smoking,alcohol consumption,and prior stroke.Clinical assessments included the admission National Institutes of Health stroke scale(NIHSS)score,Glasgow coma scale(GCS)score,and Alberta stroke program early CT score(ASPECTS).Etiology was classified using the trial of Org 10172 in acute stroke treatment(TOAST)criteria(atherosclerotic,cardioembolic,other determined etiology,undetermined etiology).Treatment details encompassed the time window from onset to puncture(OPT;≤6h,>6-<12h,12-24h),occlusion site(internal carotid artery,M1 or M2 segment of the middle cerebral artery,A1 segment of the anterior cerebral artery,tandem occlusion),pre-procedural intravenous thrombolysis,revascularization technique(mechanical thrombectomy,direct angioplasty,or mechanical thrombectomy plus rescue angioplasty)and procedural time metrics(OPT,puncture-to-recanalization time,and onset-to-recanalization time)were recorded.Admission laboratory values included neutrophil count,lymphocyte count,platelet count,fibrinogen,glucose,neutrophil-to-lymphocyte ratio(NLR),and systemic immune-inflammation index(SII).On post-recanalization DSA,the presence of EVD was denoted as EVD+,and its absence as EVD-.The presence of CB was denoted as CB+,and its absence as CB-.EVD+CB-standed for the presence of EVD with the absence of CB,while EVD-CB+standed for the absence of EVD with the presence of CB.A composite sign of EVD+CB+was defined as the presence of both,while EVD+/CB+as either(EVD and/or CB).Patients were evaluated for the occurrence of HT,PH2,and sICH within 72 hours post-procedure.Patients with any type of intracranial hemorrhage were assigned to the HT group,while those had no intracranial hemorrhage assigned to the non-HT group.PH2 group was consisted of patients with a hematoma exceeding 30%of the infarct area with significant mass effect,or hemorrhage remote from the infarct zone.While patients with any intracranial hemorrhage associated with neurological deterioration(an increase in the NIHSS total score by≥4 points or an increase in any single NIHSS item score by≥2 points from baseline)were signed to the sICH group.Variables showing statistically significant differences(between the HT group and the three other groups)in univariate comparisons were selected via stepwise forward regression for inclusion in multivariate Logistic regression analyses to identify independent factors associated with the occurrence of HT,PH2,and sICH within 72 hours after EVT.Receiver operating characteristic(ROC)curves were plotted,and the area under the curve(AUC)was calculated to assess the predictive performance of the EVD+CB+and EVD+/CB+signs for HT,PH2,and sICH.Results A total of 190 patients with anterior circulation LVO-AIS who achieved successful recanalization after EVT were included.There were 112 males and 78 females,aged 25-84 years with a mean age of 63±14 years.There were 39 patients(20.5%)in HT group,18 patients(9.5%)in PH2 group,and 18 patients(9.5%)in the sICH group;among these,13patients(6.8%)had both PH2 and sICH.Immediate post-procedural DSA revealed EVD+in 20 patients(10.5%),CB+in 45 patients(23.7%),EVD+CB-in 5 patients(2.6%),EVD-CB+in 30 patients(15.8%),and EVD+CB+in 15 patients(7.9%).(1)Compared to patients without HT,those in the HT group had significantly higher admission NIHSS scores,blood glucose,NLR,and SII,and significantly lower admission GCS scores,ASPECTS,lymphocyte counts,and platelet counts(all P<0.05).The proportions of patients with EVD-CB+,EVD+CB+,and EVD+/CB+were also significantly higher in the HT group(all P<0.05).No significant differences were found in other baseline and clinical characteristics(all P>0.05).Compared to patients without HT,those in the PH2 group had significantly lower admission ASPECTS and a higher proportion of diabetes,as well as higher blood glucose,NLR and SII(all P<0.05).The proportions of patients with EVD+CB+and EVD+/CB+were also significantly higher(both P<0.05).No significant differences were found in other characteristics(all P>0.05).Compared to patients without HT,those in the sICH group had significantly lower admission ASPECTS,lymphocyte counts,and platelet counts,and significantly higher NLR and SII(all P<0.01).The proportions of patients with EVD+CB+and EVD+/CB+were also significantly higher(both P<0.01).No significant differences were found in other characteristics(all P>0.05).(2)Multivariate Logistic regression analysis revealed that higher platelet count(OR,0.992,95%CI 0.985-0.999,P=0.022)and higher admission ASPECTS(OR,0.607,95%CI 0.424-0.871,P=0.007)were independent protective factors for HT after successful EVT recanalization.Both EVD+CB+(OR,8.664,95%CI 1.533-48.953,P=0.015)and EVD+/CB+(OR,5.866,95%CI 2.261-15.217,P<0.01)were independent risk factors for HT.Higher admission ASPECTS(OR,0.595,95%CI 0.362-0.975,P=0.039)was an independent protective factor for PH2 after successful EVT recanalization,while EVD+CB+(OR,25.450,95%CI 3.719-174.158,P<0.01)and EVD+/CB+(OR,7.747,95%CI 1.664-36.066,P=0.009)were independent risk factors for PH2.Higher admission ASPECTS(OR,0.563,95%CI 0.357-0.888,P=0.014)was an independent protective factor for sICH after successful EVT recanalization,while EVD+CB+(OR,52.576,95%CI 7.866-351.432,P<0.01)was an independent risk factor for sICH.(3)ROCcurve analysis showed that the AUC of EVD+CB+for predicting HT,PH2,and sICH after successful EVT recanalization was 0.660,0.771,and 0.716,respectively.The AUC of EVD+/CB+for predicting HT,PH2,and sICH after successful EVT recanalization was 0.754,0.837,and 0.726,respectively.Conclusions The combined evaluation of EVD and CB signs during EVT demonstrates predictive utility for HT,PH2,and sICH following successful recanalization in patients with anterior circulation LVO-AIS.It may serve as a real-time intraoperative imaging marker for identifying patients at high risk of hemorrhage.
周佳男;马振凯;周腾飞;朱良付;乔婷婷;周志龙;张洋;赵新宇;徐浩博;吴立恒;管民
450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科450003 郑州大学人民医院 河南省人民医院脑血管病科
缺血性卒中血管内治疗静脉早显毛细血管充血出血转化
Ischemic strokeEndovascular treatmentEarly venous drainageCapillary blushHemorrhagic transformation
《中国脑血管病杂志》 2026 (1)
31-42,12
河南省"三个100"计划(HNCRD202404)
评论